CEimpact

A One-Dose Wonder for Influenza Post-Exposure Prophylaxis

Overview / Abstract:	2020 was the year of COVID-19. Now it's time to focus back on influenza. Baloxavir received an indication for post-exposure prophylaxis for individuals with recent contact of the influenza virus based on the trial from Ikematsu et al. Join us to learn if baloxavir can not just treat influenza but prevent infections.
Expiration	Apr 14, 2024
Discipline(s)	Pharmacy CPE
Format	Online, Webinar / Webcast / Video
Cost	9.00
Credits / Hours	0.10
Accreditation	ACPE
Presenters / Authors / Faculty	Letitia Warunek Assistant Professor Wilkes University, School of Pharmacy
Keywords / Search Terms	CEimpact CEimpact CEimpact CEimpact CEI Impact CEI ce, influenza, infectious disease, new drugs, journal club

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map